Ukraine: crisis for people with chronic diseases
April 25, 2022Sales and Marketing
Preliminary results from an ongoing nationwide health needs assessment, conducted by WHO in partnership with Premise, indicate that one in …
Vivesto signs agreement with CRO to evaluate anti-cancer drug formulations
April 22, 2022Medical Communications
Vivesto AB, an oncology-focused pharmaceutical company, has announced that it is advancing research into its proprietary drug delivery formulations, and …
Orasis Pharmaceuticals announces positive Phase III results of eye drop candidate
April 22, 2022Medical Communications
Orasis Pharmaceuticals has announced that the Phase III NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of …
FDA approves Phase III Acute Respiratory Distress Syndrome (ARDS) Trial
April 22, 2022Medical Communications
The FDA has approved Direct Biologics to proceed with its Phase III clinical trial into the treatment of Acute Respiratory …
WHO “strongly recommends” Paxlovid, calls for wide distribution from Pfizer
April 22, 2022Medical Communications
WHO has endorsed the use of Pfizer’s oral antiviral treatment for high-risk patients with mild COVID-19, following an analysis of …
NIHR-supported trial reveals vaccine boosters maintain immunity three months on
April 21, 2022Business Services
Latest results form the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses …
FDA’s Cancer Advisory Committee to evaluate safety of P13K inhibitors
April 21, 2022Business Services
The FDA’s Oncologic Drugs Advisory Committee is holding a meeting today to discuss safety findings across the entire class of …
PacBio and Children’s Mercy Kansas City expand collaboration in rare disease
April 21, 2022Business Services
PacBio has announced an expanded research collaboration with Children’s Mercy Kansas City, to use the multi-omics capabilities of PacBio’s Sequel …
New Programme to tackle health disparities and inequalities for women with heart failure
April 21, 2022Business Services
Women diagnosed with heart failure have worse outcomes compared to men, in spite of a similar prevalence of the chronic …
Takeda Nuvaxovid COVID-19 vaccine approved in Japan
April 20, 2022Research and Development
Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …
Care to Collaborate: Cydar Medical announces partnership with Medtronic
April 20, 2022Research and Development
Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps …
Study initiated for first miniaturised robotic-assisted surgery platform
April 20, 2022Research and Development
Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …
NHS Health Chief calls for return of facemasks and social distancing
April 20, 2022Research and Development
Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …
AstraZeneca drug granted FDA Priority Review
April 19, 2022Manufacturing and Production
AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …
FDA accept New Drug Application for GSK’s daprodustat
April 19, 2022Manufacturing and Production
GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …
VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial
April 13, 2022Research and Development
VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …
NICE recommends avelumab for urothelial cancer patients
April 13, 2022Research and Development
NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …
FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall
April 13, 2022Research and Development
The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …
It could take up to six years to clear the patient backlog in Europe
April 13, 2022Research and Development
Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …
Tjaopack announces completion of Netherlands facility expansion
April 12, 2022Manufacturing and Production
Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
